Request Free Sample
×
Japan Ascites Market
ID: MRFR/HC/54589-HCR
200 Pages
June 2025
Japan Ascites Market Research Report: By Type (Transudative Ascites, Exudate Ascites), By Diagnosis (Ultrasound, CT Scan, Laparoscopy, Angiography), By Treatment (Surgeries) andBy End User (Hospitals & Clinics, Ambulatory Surgical Center, Diagnostic Centers)- Forecast to 2035
Industry Developments
Recent developments in the Japan Ascites Market highlight a growing interest in innovative treatments for managing this condition, primarily associated with liver diseases like cirrhosis and cancer. Companies such as Pfizer, Chugai Pharmaceutical, and Takeda Pharmaceutical are actively involved in Research and Development initiatives aimed at improving treatment efficacy. In March 2023, Eisai continued to expand its oncology pipeline, with a focus on therapies that may benefit patients suffering from ascites. The market has seen substantial investment, as reflected in the increase in valuations among leading companies like Daiichi Sankyo and Novartis, which are striving to enhance patient outcomes. Merger and acquisition activities have included Chugai Pharmaceutical's discussions regarding collaborations with international firms to enhance their market reach and product offerings in this segment. Additionally, in 2021, Astellas Pharma reported a strategic acquisition of a biotech firm, further consolidating its position in the treatment landscape. The increasing prevalence of liver diseases in Japan, which is exacerbated by lifestyle factors, is fueling demand for effective therapies, thereby shaping the future of the Japan Ascites Market.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 38.7(USD Million) |
| MARKET SIZE 2024 | 40.8(USD Million) |
| MARKET SIZE 2035 | 128.64(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.004% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Pfizer, Chugai Pharmaceutical, Kyowa Kirin, Eisai, BristolMyers Squibb, Alexion Pharmaceuticals, Novartis, Daiichi Sankyo Company, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Otsuka Pharmaceutical, Sawai Pharmaceutical, Takeda Pharmaceutical, Astellas Pharma |
| SEGMENTS COVERED | Type, Diagnosis, Treatment, End User |
| KEY MARKET OPPORTUNITIES | Rising prevalence of liver diseases, Increasing demand for innovative treatments, Growth in diagnostic technologies, Expanding geriatric population, Enhanced government funding for healthcare. |
| KEY MARKET DYNAMICS | increasing cancer prevalence, rising aging population, advanced diagnostic technologies, improved treatment options, growing awareness and education |
| COUNTRIES COVERED | Japan |
FAQs
What is the expected market size of the Japan Ascites Market in 2024?
The Japan Ascites Market is expected to be valued at 40.8 million USD in 2024.
What is the projected market size of the Japan Ascites Market by 2035?
By 2035, the Japan Ascites Market is projected to reach a value of 128.64 million USD.
What is the expected CAGR for the Japan Ascites Market from 2025 to 2035?
The Japan Ascites Market is anticipated to grow at a CAGR of 11.004% from 2025 to 2035.
What are the market values for Transudative Ascites in 2024 and 2035?
Transudative Ascites is valued at 18.0 million USD in 2024 and is expected to increase to 56.64 million USD by 2035.
What are the market values for Exudate Ascites in 2024 and 2035?
Exudate Ascites is valued at 22.8 million USD in 2024, with a forecasted value of 71.99 million USD in 2035.
Who are the major players in the Japan Ascites Market?
Key players include Pfizer, Chugai Pharmaceutical, Kyowa Kirin, Eisai, and Bristol-Myers Squibb among others.
What trends are currently shaping the Japan Ascites Market?
Emerging trends in the Japan Ascites Market include advancements in treatment options and increased healthcare spending.
What challenges does the Japan Ascites Market face?
The Japan Ascites Market faces challenges such as high costs of innovative therapies and regulatory hurdles.
What is the market growth rate for the Japan Ascites Market?
The Japan Ascites Market is experiencing significant growth due to rising incidences of liver diseases and healthcare advancements.
How does competition impact the Japan Ascites Market?
Intense competition among major pharmaceutical companies drives innovation and results in diverse treatment options in the Japan Ascites Market.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment